Medical Letter on Drugs and Therapeutics
The Medical Letter on Drugs and Therapeutics is an independent, peer-reviewed, nonprofit publication that offers unbiased critical evaluations of drugs, with special emphasis on new drugs, to physicians and other members of the health professions. It evaluates virtually all new drugs and reviews older drugs when important new information becomes available on their usefulness or adverse effects.
This is a bi-monthly letter targeting identified problematic therapeutic issues (brief, simple, practical messages). The process involves a literature review and development of the message by different working groups of the Therapeutics Initiative. A draft of the letter is reviewed by specialists who are expert in the particular therapeutic area and members of the Scientific Information and Education Committee before the letter is disseminated. The Therapeutics Initiative is a member of the International Society of Drug Bulletins.
Lexicomp provides clear, concise, point-of-care drug information, including dosing, administration, warnings and precautions, as well as clinical content, such as clinical practice guidelines, IV compatibility from Trissel's 2 Clinical Pharmaceutics Database, and other tools. GSA scheduled.
Access restrictions: Lexicomp is licensed by DHMC Clinical Pharmacy for use at clinical sites and Dartmouth Campus. Off-campus access requires VPN (DHMC or Dartmouth.)
The Micromedex Academic Program provides Dartmouth students and faculty with access to clinical decision support information from Micromedex Healthcare Solutions. According to the license:
The Products are intended solely for demonstration purposes and for the purpose of training students in the use of the Products, not for clinical purposes, and not for emergency response purposes. The Products are to be used under the supervision of Licensee's teaching staff.
The products available include:
Access restrictions: Micromedex is licensed for use by Dartmouth College / DMS (IP Address).
Free drug and disease information on the Web; requires registration. Includes free downloads for mobile devices, as well.
From the Drug Effectiveness Review Project, Oregon Health and Science University. Provides information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes.